$40.47
-0.27%Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation
Base year metrics used for projections
Forecast period and terminal assumptions
Calculation flow from present value to intrinsic value per share
Operating Cash Flow - Maintenance CapEx = Owner Earnings
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | Year 9 | Year 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $100.7M | $86.8M | $74.7M | $64.4M | $55.4M | $47.7M | $41.1M | $35.4M | $30.5M | $26.3M |
| Maintenance CapEx | -$6.6M | -$5.7M | -$4.9M | -$4.2M | -$3.6M | -$3.1M | -$2.7M | -$2.3M | -$2.0M | -$1.7M |
| Owner Earnings | $94.1M | $81.1M | $69.8M | $60.1M | $51.8M | $44.6M | $38.4M | $33.1M | $28.5M | $24.5M |
| Discount Factor | 0.926 | 0.857 | 0.794 | 0.735 | 0.681 | 0.630 | 0.583 | 0.540 | 0.500 | 0.463 |
| Present Value | $87.1M | $69.5M | $55.4M | $44.2M | $35.2M | $28.1M | $22.4M | $17.9M | $14.2M | $11.4M |
Continue your INSP research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.